Pharmafile Logo
Pharmafocus logo
Advanced Search

More people self-funding routine operations as NHS waiting lists hit record levels

October 25, 2021
Sales and Marketing

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …

News

Novartis Phase III study into canakinumab does not meet primary endpoint

October 25, 2021
Sales and Marketing

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …

News

AstraZeneca biliary cancer drug shows improved survival rate in patients

October 25, 2021
Sales and Marketing

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …

News

Companion test for lung cancer approved by FDA

October 22, 2021
Medical Communications

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …

News

Servier Phase III colorectal cancer trial fails to meet primary endpoint

October 22, 2021
Medical Communications

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …

News

CDC approves the mixing of COVID shots

October 22, 2021
Medical Communications

The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …

News

Xtrava Health Receives Emergency Use Authorisation for COVID-19 Ag Test

October 22, 2021
Medical Communications

The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. The easy-to-use, rapid lateral …

News

‘Plan C’ COVID response is urgent, doctors say

October 21, 2021
Business Services

UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals …

News
mat-napo-pij34zrzeew-unsplash

Open Orphan to conduct first-ever COVID-19 human challenge trial

October 21, 2021
Business Services

Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study. The company has signed …

News

Novartis extend COVID-19 vaccine deal with BioNTech

October 21, 2021
Business Services

Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish …

News

Small Pharma’s Phase IIa DMT-assisted therapy begins

October 21, 2021
Business Services

Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its …

News

IXICO partner with Microsoft to enhance AI platform

October 20, 2021
Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …

News

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021
Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …

News

Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit

October 20, 2021
Research and Development

Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …

News
mufid-majnun-oi20ehignd4-unsplash

UK COVID deaths highest since March – Doctors call for urgent return of restrictions

October 20, 2021
Research and Development

Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …

News

England care staff shortage puts thousands at risk

October 20, 2021
Research and Development

Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …

News

Hyloris announces approval of new drug for pain management

October 19, 2021
Manufacturing and Production

Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …

News

National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines

October 19, 2021
Manufacturing and Production

Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …

News

Lipocine and Antares Pharma enter agreement to commercialise TLANDO®

October 19, 2021
Manufacturing and Production

Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …

News

Global Heart Hub and Novartis form partnership to combat ASCVD

October 19, 2021
Manufacturing and Production

Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025